Cellular Biomedicine Group Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$127.51 | $130.51 | 12.15% | 11 | $322.99B |
| ABT | Abbott Laboratories | Outperform |
9
|
$105.90 | $118.92 | 18.04% | 7 | $183.76B |
| PFE | Pfizer | Outperform |
2
|
$27.81 | $32.87 | 9.67% | 6 | $157.48B |
| MDT | Medtronic | Outperform |
11
|
$81.69 | $92.47 | 17.52% | 9 | $108.47B |
| GSK | GSK | Outperform |
12
|
£17.34 | £17.30 | 12.46% | 12 | £70.69B |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $15.89M |
| 542765 | Transpact Enterprises | - |
0
|
361.00 | 0.00 | -100.00% | 0 | 139.61M |